Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LOC285847 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ANOS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
POLE2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDE3B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM178B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHCHD5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GXYLT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SRPK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HDGFRP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LEPROT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VPS37A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NCAPD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DDX46 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PMS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DMBT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADAM22 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101929356 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PECR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNX25 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on